Herniorrhaphy Study for Opioid Elimination
ClinicalTrials.gov NCT03907176
Research payments
$1,202,255
Through program year 2022, $1,202,255 in research payments was reported against Herniorrhaphy Study for Opioid Elimination, across 202 payments, paid by Heron Therapeutics, Inc..
- Paid by
- Heron Therapeutics, Inc.
- ClinicalTrials.gov
- NCT03907176
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $113,542 | 32 |
| 2021 | Research | $410,073 | 85 |
| 2020 | Research | $678,640 | 85 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Phillip Shadduck Durham, NC Named on 12 payments
- Brent Yeung Orange, CA Named on 11 payments
- Christopher Page Stony Brook, NY Named on 11 payments
- Julio Arronte Miami, FL Named on 10 payments
- Hong-Der Lin La Mesa, CA Named on 10 payments
- Tristan Weaver Columbus, OH Named on 10 payments
- Timothy Beard Bend, OR Named on 10 payments
- David Arnold Dallas, TX Named on 9 payments
- Charles Luke Cranberry Twp, PA Named on 9 payments
- Jean Eloy Newark, NJ Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.